Hepatic gene expression in morbidly obese women: implications for disease susceptibility (Q38510794)

3 September 2017

title

Hepatic gene expression in morbidly obese women: implications for disease susceptibility (English)

1 reference

3 September 2017

0 references

Marshall B Elam

1

1 reference

3 September 2017

George S Cowan

2

1 reference

3 September 2017

Robert J Rooney

3

1 reference

3 September 2017

M Lloyd Hiler

4

1 reference

3 September 2017

Chandrahasa R Yellaturu

5

1 reference

3 September 2017

Xiong Deng

6

1 reference

3 September 2017

George E Howell

7

1 reference

3 September 2017

Edwards A Park

8

1 reference

3 September 2017

Ivan C Gerling

9

1 reference

3 September 2017

Divyan Patel

10

1 reference

3 September 2017

J Christopher Corton

11

1 reference

3 September 2017

Lauren M Cagen

12

1 reference

3 September 2017

Henry G Wilcox

13

1 reference

3 September 2017

Malay Gandhi

14

1 reference

3 September 2017

Micheal H Bahr

15

1 reference

3 September 2017

Micheal C Allan

16

1 reference

3 September 2017

Linus A Wodi

17

1 reference

3 September 2017

George A Cook

18

1 reference

3 September 2017

Thomas A Hughes

19

1 reference

3 September 2017

Rajendra Raghow

20

1 reference

3 September 2017

publication date

5 March 2009

1 reference

3 September 2017

1 reference

3 September 2017

volume

17

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

1563-1573

1 reference

Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Obesity: impediment to postsurgical wound healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Hepatocellular carcinoma: recent trends in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

The impact of obesity on the incidence and treatment of gynecologic cancers: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Please pass the chips: genomic insights into obesity and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: microarray analysis of lipid-related gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Bariatric surgery: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Expression monitoring by hybridization to high-density oligonucleotide arrays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: a microarray gene expression profile.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Gender-specific association of a perilipin gene haplotype with obesity risk in a white population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Hepatic cholesterol metabolism in human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Fatty acid elongases in mammals: their regulation and roles in metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Insulin resistance and chronic cardiovascular inflammatory syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Impact of obesity on treatment of chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Obesity predicts increased overall complications following pancreas transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Obesity and the risk of early and late mortality after coronary artery bypass graft surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Dermatopontin, a novel player in the biology of the extracellular matrix

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

IGF-binding protein-2 protects against the development of obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Hepatic leptin signaling in obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Leptin: a review of its peripheral actions and interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Cytochromes P450 in the bioactivation of chemicals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

GSTT2 promoter polymorphisms and colorectal cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Regulation of mTOR and cell growth in response to energy stress by REDD1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

The role of 17 beta-hydroxysteroid dehydrogenases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Enterohepatic bile salt transporters in normal physiology and liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.49

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.49

1 reference

release_hxfgkzvk3rfx5nksi26tvorj6e

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hxfgkzvk3rfx5nksi26tvorj6e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference